Floating Button
Home News Offer

SMG’s CEO, non-executive chairman and executive director make 37 cents per share privatisation bid for company

Felicia Tan
Felicia Tan • 5 min read
SMG’s CEO, non-executive chairman and executive director make 37 cents per share privatisation bid for company
The cash price is a premium of 18.1% over the one-month VWAP of shares traded on the SGX. Photo: SMG
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Catalist-listed Singapore Medical Group (SMG) has received a privatisation bid that will value the company at $180.0 million based on the 486.38 million shares in the company’s issued and paid-up capital. The offer is made with a view to delist and privatise the company.

On Sept 13, TLW Success (the offeror) has, through Ernst & Young, made a voluntary conditional general offer of 37 cents per share in cash to SMG’s shareholders.

The shareholders in TLW Success are Tony Tan Choon Keat, Dr Beng Teck Liang and Dr Wong Seng Weng. Tan is the non-executive chairman of SMG, Dr Beng is the executive director and CEO of SMG, while Dr Wong is the executive director of SMG. As at Sept 13, TLW Success has an issued and paid-up share capital of $3 comprising three ordinary shares held equally by the trio. Tan and Dr Beng are on the board of directors in TLW Success.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.